» Articles » PMID: 28426876

Genome-wide DNA Methylation Analysis During Non-alcoholic Steatohepatitis-related Multistage Hepatocarcinogenesis: Comparison with Hepatitis Virus-related Carcinogenesis

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2017 Apr 21
PMID 28426876
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to clarify the significance of DNA methylation alterations during non-alcoholic steatohepatitis (NASH)-related hepatocarcinogenesis. Single-CpG-resolution genome-wide DNA methylation analysis was performed on 264 liver tissue samples using the Illumina Infinium HumanMethylation450 BeadChip. After Bonferroni correction, 3331 probes showed significant DNA methylation alterations in 113 samples of non-cancerous liver tissue showing NASH (NASH-N) as compared with 55 samples of normal liver tissue (NLT). Principal component analysis using the 3331 probes revealed distinct DNA methylation profiles of NASH-N samples that were different from those of NLT samples and 37 samples of non-cancerous liver tissue showing chronic hepatitis or cirrhosis associated with hepatitis B virus (HBV) or hepatitis C virus (HCV) infection (viral-N). Receiver operating characteristic curve analysis identified 194 probes that were able to discriminate NASH-N samples from viral-N samples with area under the curve values of more than 0.95. Jonckheere-Terptsra trend test revealed that DNA methylation alterations in NASH-N samples from patients without hepatocellular carcinoma (HCC) were inherited by or strengthened in NASH-N samples from patients with HCC, and then inherited by or further strengthened in 22 samples of NASH-related HCC (NASH-T) themselves. NASH- and NASH-related HCC-specific DNA methylation alterations, which were not evident in viral-N samples and 37 samples of HCC associated with HBV or HCV infection, were observed in tumor-related genes, such as WHSC1, and were frequently associated with mRNA expression abnormalities. These data suggested that NASH-specific DNA methylation alterations may participate in NASH-related multistage hepatocarcinogenesis.

Citing Articles

DNA Methylation Profile in Buffy Coat Identifies Methylation Differences Between Cirrhosis with and Without Hepatocellular Carcinoma.

Lim H, El-Serag H, Luster M, Grove M, Byun J, Jung Y Cancers (Basel). 2025; 17(2).

PMID: 39858049 PMC: 11763440. DOI: 10.3390/cancers17020266.


Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression.

Bilbao I, Recalde M, Daian F, Herranz J, Elizalde M, Inarrairaegui M J Physiol Biochem. 2024; 80(4):865-879.

PMID: 39305372 PMC: 11682006. DOI: 10.1007/s13105-024-01045-8.


Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma.

Yan W, Rao D, Fan F, Liang H, Zhang Z, Dong H Front Oncol. 2024; 14:1407434.

PMID: 38962270 PMC: 11220127. DOI: 10.3389/fonc.2024.1407434.


Molecular pathological approach to cancer epigenomics and its clinical application.

Kanai Y Pathol Int. 2024; 74(4):167-186.

PMID: 38482965 PMC: 11551818. DOI: 10.1111/pin.13418.


Detection of hepatocellular carcinoma methylation markers in salivary DNA.

Mezzacappa C, Wang Z, Lu L, Risch H, Taddei T, Yu H Biosci Rep. 2024; 44(3).

PMID: 38457142 PMC: 10958141. DOI: 10.1042/BSR20232063.


References
1.
Brunt E, Janney C, Di Bisceglie A, Neuschwander-Tetri B, Bacon B . Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94(9):2467-74. DOI: 10.1111/j.1572-0241.1999.01377.x. View

2.
McElhinny A, Li J, Wu L . Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene. 2008; 27(38):5138-47. DOI: 10.1038/onc.2008.228. View

3.
Toyokawa G, Cho H, Masuda K, Yamane Y, Yoshimatsu M, Hayami S . Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia. 2011; 13(10):887-98. PMC: 3201566. DOI: 10.1593/neo.11048. View

4.
Arai E, Kanai Y . DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status. Epigenomics. 2011; 2(3):467-81. DOI: 10.2217/epi.10.16. View

5.
Haladyna J, Yamauchi T, Neff T, Bernt K . Epigenetic modifiers in normal and malignant hematopoiesis. Epigenomics. 2015; 7(2):301-20. DOI: 10.2217/epi.14.88. View